Genes for the 290 amino acid, 33-34 kDa cytosolic acetyltransferases (NAT1* and NAT2*) from rat and hamster were cloned and expressed in Escherichia coli. Active clones were selected by a simple visual test for their ability to decolorize 4-aminoazobenzene in bacterial medium by acetylation. These recombinant acetyltransferases were analyzed for: (i) N-acetyltransferase, which was assayed by the rate of acetyl coenzyme A-dependent N-acetylation of 2-aminofluorene (2-AF) or 4-aminoazobenzene ( SDS-PAGEAVestern blot analysis of the recombinant acetyltransferases gave apparent relative molecular weights (MW r ) of -31 kDa for both NATls and rat NAT2 and -29 kDa for hamster NAT2. Comparable MW r values were observed for native hamster liver NAT1 and NAT2 and for rat NAT1 under the same conditions. Although we did not detect NAT2-Hke activity in rat liver cytosol previously, the present data show that the rat NAT2* gene does code for a functional acetyltransferase, with properties similar to those of hamster liver NAT2. The data also indicate that at low substrate concentrations, NAT1 would apparently play the predominant role in vivo in A'-acetylation and iV,O-acyltransfer of aromatic amine derivatives, including their metabolic activation to DNAreactive agents.
Introduction
Genes for two closely related, 33-35 kDa cytosolic arylamine N-acetyltransferases (NATs*; EC 2.3.1.5) termed NAT1* and NAT2* (reviewed in 1) have been found in all vertebrates © Oxford University Press analyzed, including humans (2,3), mice (4), hamsters (5, 6) , rats (7) and rabbits (8) . Their catalytic activities include A'-acetylation, O-acetylation and A'.O-acyltransfer of carcinogenic aromatic amine metabolites, although the relative reaction velocities and K m values for these two acetyltransferase isozymes differ markedly. These acetyltransferases have been implicated in the genotoxic potential of exogenous aromatic amines such as benzidine and 4-aminobiphenyl, known bladder carcinogens in humans (9) . They metabolically activate arylhydroxylamine or arylhydroxamic acid derivatives of these compounds by O-acetylation to yield A/-acetyoxyarylamines (reviewed in 10). These ester derivatives are DNA reactive and spontaneously form DNA adducts, principally at C8 of deoxyguanine, which have been shown in bacterial systems to be mutagenic (reviewed in 11, 12) .
The tissue distribution of acetyltransferase activity correlates with susceptibility to tumor induction by arylamines (e.g. mammary tissue; reviewed in 10). The carcinogenic potential of the A'-oxidized aromatic amines corresponds to their efficacy as precursors for the synthesis of A'-acyloxyarylamines by acetyltransferase activity (10) . Furthermore, most DNA adducts produced by aromatic amines are deacetylated, consistent with their formation from these A'-acyloxyarylamines. In situ RNA hybridization with NAT1*-or A 7 /172*-specific probes indicates that acetyltransferase transcripts, which are present in nearly all tissues analyzed, are predominantly for NAT1 (13) . The Nand O-acetylation as well as A'.O-acyltransferase activities in CD rat liver cytosol are all attributable to a single NAT 1-likẽ 30 kDa acetyltransferase with a pi of ~4.5 (14) . A second acetyltransferase has not been detected biochemically or immunochemically in these animals (14) . In contrast, Syrian golden hamster liver cytosol contains both an analogous NAT1-like activity as well as a second acetyltransferase with a pi of ~5.2, which accounts for the majority of cytosolic 2-aminofluorene (2-AF) NAT and PABA NAT activity [where the acetyl donor is acetyl coenzyme A (AcCoA)], but has little O-or A'.O-acyltransferase activity (15) (16) (17) .
The purpose of the present study was to clone the rat and hamster NAT1* and NAT2* genes and express them as recombinant proteins in bacteria to establish whether the rat NAT2* gene product is functional and to carry out direct comparisons of the catalytic and biochemical properties of these two acetyltransferases. This should help define the relative roles of the acetyltransferase isozymes in metabolic activation of exogenous arylamines and in the metabolism of possible endogenous substrates. Corp. (Rockland, ME). Deoxyribonucleoside tnphosphates were purchased from Pharmacia (Piscataway, NJ). N-Hydroxy-N-acetyl^-aminofluorene (N-OH-[ri/i£-3 H]AAF) (10-30 mCi/mmol) was synthesized by Dr Mei-Sie Lee (Department of Chemical Carcinogenesis, Michigan Cancer Foundation) (18) 
Materials and methods

Chemicals and other reagents
Enzymes
The following enzymes were purchased from the sources indicated: UlTma polymerase from Perkin Elmer (Norwalk, CT), T4 DNA ligase, BamHl and EcoRl from BRL (Gaithersberg, MD) and calf intestinal alkaline phosphatase from Boehringer Mannheim Biochemicals (Indianapolis, IN).
Extraction of DNA
DNA was purified from liver from Syrian golden hamsters or Fischer 344 rats (both from Charles River Breeding Laboratories, Wilmington, MA) by a guanidine thiocyanate/cesium chloride method (19, 20) .
PCR amplification of NAT* genes
PCR amplification (21) was carried out essentially as before for acetyltransferase genes (17, 22) , but using Ultma polymerase and the reaction ingredients specified by the supplier (Perkin Elmer). PCR primers were used at 0.5 nM each (synthesized by the Macromolecular Core Facility, Wayne State University School of Medicine). Primers for the 5'-end of the NAT* coding region were (plus strand primers, given 5'-»3'): 5'fs, CTTAGGAAACCATGGA-CATTGAAGC; p5', GCGAATTCATATGGACATCGAAGCATA. Primers for the 3'-end of the coding region were (minus strand primers, given 5'->3'). rl/ 876, ACCCTAAATAGTAAAAACTAGTTCACCAT; h 1/876, ACCCTAAAT-ACTAAAAGATAGGTTACCAT; 2/876, ATTCTAAATGGTAAAAAATCTA-TCACCAT; rl/p3', CGCGGATCCTAAATAGTAAAAACGAGTT; hl/p3', CGCGGATCCTAAATACTAAAAGATAGGTTA; 2/p3', CGCGGATCCTA-AATGGTAAAAAATCGAT. The thermal cycle used was: one cycle of 95°C for 5 min, 40°C for 2 mm and 70°C for 1 min; 34 cycles of 95°C for 1 min, 54°C for 2 min and 70°C for 1 min; then 70°C for 7 min. NAT* genes were amplified from rat or hamster genomic DNAs with the indicated PCR primers: rat NATI*, with primers 5'fs and rl/876; rat NAT2*, with 5'fs and 2/876; hamster NATI*, with 5'fs and hl/876; hamster NAT2*, with 5'fs and 2/876. The PCR products (-890 bp) were purified by electrophoresis through NuSieve agarose gels in TAE buffer (40 mM Tris-acetate, 2 mM EDTA, pH 8.1). To generate terminal £coRI and BamHl sites for hgation into pKEN2, the sizepurified DNAs were re-amplified for 20 cycles with the following PCR adapter primers: rat NATI*, p5' and rl/p3'; rat NAT2*, p5' and 2/p3'; hamster NAT1*, p5' and hl/p3'; hamster NAT2*, p5' and 2/p3'. The PCR-amplified DNAs were then restricted with £coRI and BamHl and recovered by ethanol precipitation (23) .
Preparation of bacterial expression vectors for recombinant NATs
The IPTG-inducible bacterial expression vector pKEN2 and Eschenchia coli XA90(F7ac/ ql ) cells were obtained from Dr G.L.Verdine (Department of Chemistry, Harvard University). [This expression system was also used by Dupret and Grant (24) to express the human NATI* and NAT2* genes in XA90 cells.] pKEN2 plasmid DNA was purified from bacterial cells by an alkaline lysis method (20) . In preparation for cloning, the pKEN2 vector was cut with £coRI and BamHl, dephosphorylated with calf intestinal alkaline phosphatase and then extracted with neutralized phenol and chloroform/ isoamyl alcohol (24:1). The DNA was precipitated by addition of ammonium acetate and isopropanol to final concentrations of 1 M and 50% respectively. The DNA was recovered by centrifugation and dissolved in TE buffer (5 mM Tns-HCl, 0.1 mM EDTA, pH 8.0). This pKEN2 vector was then ligated with an equimolar amount of fcoRI/fiamHI-restricted NATI* or NAT2* gene DNA with T4 DNA ligase under conditions recommended by the supplier (BRL), giving pKENl/NAT* vectors.
Screening of NAT* clones for N-acetyltransferase activity
Eschenchia coli XA90(F'lact^) was transformed with plasmid DNA as described by Hanahan (25), then plated on agar dishes supplemented with LB medium (10 g Bacto-tryptone, 10 g sodium chloride and 5 g Bacto-yeast extract per liter, pH 7.5) plus ampicillin (125 Ug/ml) and incubated overnight at 37°C. Ampicillin-resistant colonies were scored visually for NAT activity as follows. Colonies were transferred to individual wells in 96-well plates containing 100 |il aliquots of LB (26) supplemented with ampicillin (125 |ig/ml), IPTG (1 mM) and AAB (0.5 mM), then grown overnight at 37°C at 250 r.p.m. The culture medium of clones expressing active NAT was decolorized due to N-acetylation of AAB (bright yellow) to /V-acetylaminoazobenzene (colorless in LB medium). Addition to the medium of an equal volume of 50% ethanol/20% trichloroacetic acid (27) at the end of the incubation period causes a more prominent color change in NAT-positive cultures: from bright red-orange (unmodified AAB) to colorless (/V-acetylaminoazobenzene), leaving only the background color of LB medium.
Protein determination
Protein concentrations were estimated by the Bradford dye binding assay (28) using BioRad Laboratories (Hercules, CA) protein assay reagents and bovine serum albumin as the standard.
Western blot analysis
Western analysis of recombinant NAT proteins in bacterial sonicates was performed as described previously for tissue extracts (14) , except that the samples were solubilized with 1% Triton X-100 to release membrane-bound proteins prior to diluting with SDS-PAGE buffer. Briefly, the indicated aliquots of bacterial sonicate supernatant protein were electrophoresed through SDSpolyacrylamide gels and transferred to nitrocellulose membranes. NATs were detected by immunostaining with a cocktail of primary monoclonal antibodies raised against purified rat liver acetyltransferase (14) and secondary antibodies linked to alkaline phosphatase. Apparent relative molecular weights (MW r ) of the NATs were estimated by comparison with protein size markers (BioRad Laboratories, Hercules, CA). Bacterial sonicates were prepared as follows. Cultures were incubated at 37°C for ~6 h at 250 r.p m. in LB medium plus ampicillin (125 (ig/ml) and IPTG (1 mM) to induce acetyltransferase expression. Bacterial cells were centrifuged for 10 min at 1800 g at 5°C, washed once and resuspended in NaPPi buffer (50 mM sodium pyrophosphate, 2 mM dithiothreitol, pH 7.4), sonicated (29) , then centrifuged for 5 min at 13 000 g to remove insoluble debris (S9 fraction). The SI05 fraction was the supernatant after centrifugation at 105 000 g for 1 h at 5°C.
Enzyme assays
Enzyme assays were carried out on S9 bacterial sonicates. 2-AF W-acetylation was assayed by a modification of the method of Glowinski el al. (30) as described by Land et al. (14) . This assay measures the rate of transfer of [ 3 H]acetate from AcCoA to 2-AF. The AAB W-acetylalion assay was the same, but substituting AAB for 2-AF as the acetyl acceptor. N,O-Acy\-transferase activity was measured by a tRNA trapping assay for the enzymatic conversion of N-OH-[ring-3 H]AAF to its nucleotide-reactive /V-acetoxy derivative (14) . The rate of transfer of the acetyl group from arylhydroxamic acids to AAB was measured by the spectrophotometric transacetylation assay of Booth (27) , using 1 mM W-hydroxy-yV-acetyl-4-aminobiphenyl (N-OH-AABP) (acetyl donor) and 0.3 mM AAB (acetyl acceptor).
Enzyme assays were linear with time under the conditions used and were done with at least six different dilutions of bacterial extract for each substrate concentration. The activities in the sonicates were stable for at least 1 week at 5°C. The reaction velocities were calculated from the dilutions of sonicate showing a linear response (giving R values for linear regression of >0.9). Th e Vmtx ^ apparent K m values were estimated with Enzpack software (Biosoft, Cambridge, UK), using Eadie-Hofstee linear transforms of the rate data. The values reported in Tables I and II 
Results
Screening of pKEN2/NAT* clones for N-acetylation activity NATI* and NAT2* genes were selectively PCR amplified from rat and hamster genomic DNAs using gene-specific primers (17) . As estimated by agarose-ethidium bromide gel electrophoresis (26), the PCR products were -890 bp (data not shown). This is the size expected for the coding region of the acetyltransferase genes, which are intronless and contain 290 codons in mammals (3, 5, 7, 8) . The PCR products were reamplified with the p5' and p3' adaptor primers, cut with EcoRl and BamHl, then ligated into the restricted and phosphatased pKEN2 DNA. Escherichia coli Xk9Q{¥'lac^) was transformed with these recombinant vectors and plated on LB/agar/ ampicillin dishes.
Two dozen ampicillin-resistant clones of each of the rat and hamster NATs were tested for activity by the visual wholecell AAB acetylation assay in 96-well plates. Approximately 50% of the ampicillin-resistant clones were NAT-positive by this assay. Active clones were readily identifiable by loss of AAB color in 6-8 h and complete decolorization of AAB typically occurred after an overnight incubation. The pKEN2 vector alone gave no detectable activity. NAT-positive clones with the correct NAT* coding region were identified by DNA sequencing, with reference to sequences in GenBank for the Recombinant iV-acetyltransferases 
shown).] Western blot analysis
Initial Western blot analysis indicated that a significant fraction of recombinant NAT was insolubleyinactive and lost during preparation of clarified bacterial sonicates, therefore, three bacterial preparations were compared: total sonicates, S9 supernatants and S105 supernatants. To release membranebound proteins, Triton X100 was added to each of these fractions to a final concentration of 1%. As shown in Figure  1 , hamster NAT1 and NAT2 migrated with MW r of -31 and 29 kDa respectively, relative to the protein size standards. Both rat NAT1 and NAT2 migrated at -31 kDa under these conditions. The amount of NAT protein present in the three fractions differed for the clones analyzed, but the MW r of NATs present in the S9 and S105 supernatants were consistent with those in the total sonicates.
Relative acetyltransferase activities
The relative 2-AF A/-acetylation and N,O-acetyltransferase activities are given in Table I for the bacterially expressed rat and hamster NAT Is and NAT2s. The /V-acetylation reaction velocities of both NAT2s showed a first order dependence on increasing concentrations of the substrates 2-AF and AAB between 5 and 100 uM (where the AcCoA concentration was 0.4 mM), giving apparent K m values of 22-32 and 62-138 (J.M respectively (Table I) . Under the same conditions, the rates of N-acetylation for the two NAT Is declined from 50 to 80% (data not shown). However, N-acetylation by the NAT Is at acceptor concentrations of 1-5 (i.M followed MichaelisMenten kinetics and these data gave K m values of 0.2-0.9 \iM for 2-AF and AAB (Table I) .
There were marked isozyme-specific differences in the ratios of N-acetylation of 2-AF versus AAB (Table I) , which were -1 for the two NATls and >7 for the two NAT2s. There were also isozyme-specific differences in the acetyl group donor preference (Table IT) at the substrate concentrations used in the Booth transacetylation assay (acetyl donor 1 mM N-OH-AABP, acceptor 0.3 mM AAB). The ratio of AAB jV-acetylation (acetyl donor 1 mM AcCoA, acceptor 0.3 mM AAB) to Booth transacetylation activity was =£0.2 for the NATls, but -3 for the NAT2s. In addition, the AAB A'-acetylation rates for the NAT2s were -7-fold greater than for the NATls. Similar data were obtained for other independent clones of the NATls and NAT2s (data not shown). These data indicate that AcCoA is a far more efficient acetyl donor for the NAT2s than are the A'-acetyl arylhydroxamic acids under these conditions.
Discussion
We have reported here that NAT1* and NAT2* genes from both rat and hamster were cloned into the IPTG-inducible Rat AT1
AT2
Hamster AT1
Sonicate S9 S105 Fig. 1 . Western blot analysis of bacterially expressed acetyltransferases. SDS-PAGEAVestern blot analyses were run on the indicated aliquots of either total bacterial sonicates, S9 or S105 supematants prepared from IPTG-induced E.coli XA90 clones expressing the recombinant acetyltransferases. ATI, NAT1; AT2, NAT2. The amounts of bacterial protein run were: rat NAT1 and hamster NAT2, 5 ng; rat NAT2 and hamster NAT1, 100 |ig. The asterisks indicate the 31 kDa protein molecular weight standard.
vector pKEN2 and expressed in E.coli XA90. A convenient 96-well plate assay for AAB N-acetylation activity is described for direct visual identification of clones producing active acetyltransferases. Expression of appropriately sized recombinant NAT proteins was confirmed by Western blot analysis and kinetic parameters were determined for their Nacetyltransferase and /V,O-acyltransfer activities. Western blot analysis indicated that although hamster and rat NAT1 and NAT2 have calculated molecular weights of 33.4-33.9 kDa, the MW r of their bacterially expressed recombinants as estimated by SDS-PAGE were significantly smaller: 31 kDa for hamster and rat NAT Is and 29 kDa for hamster NAT2. Comparable mobilities were seen previously for the native acetyltransferases in rat and hamster liver cytosols under the same conditions (14, 17) . In the present experiments, the recombinant rat NAT2 appeared to have approximately the same MW r as the NATls. These shifts to faster electrophoretic mobility are not likely to be a consequence of post-translational modifications, since such modifications differ in bacteria and mammalian cells. Recombinant hamster NAT1 and NAT2 expressed in COS-1 cells showed analogous mobility differences on Western blots (5, 32) . When expressed in E.coli with an N-terminal 'flag' extension, hamster NAT1 migrated at ~32 kDa (33) under similar conditions.
The kinetic parameters for the two NAT isozymes differed markedly. Although the bioactivation of arylamine derivatives in vivo by acetylation is primarily attributable to NAT1, both recombinant rat and hamster NAT2s were found to have significant N,O-acyltransferase activity. However, their apparent K m values for N-OH-AAF were -20-to 70-fold higher than those for the NATls. Also, the ratios of the rates of N-acetylation of AAB with AcCoA relative to N-OH-AABP as donor were up to 30-fold higher for NAT2 than NAT1. The rates of 2-AF and AAB A'-acetylation by both NAT isozymes followed simple first order Michaelis-Menten kinetics, but at markedly different acceptor substrate concentration ranges: at 5-100 \iM for the NAT2s and at <5 \iM for the NATls (with rate declines of up to 80% between 5 and 100 (iM). Both Nand O-acetyltransferase reactions have been reported to operate through a ping-pong Bi Bi mechanism, in which the acetyl group is transferred from AcCoA to a cysteinyl residue in NAT, then to the arylamine or hydrazine substrates (34) . Further work will be needed to determine the mechanism and biological implications of the decline in N-acetylation rates by the NATls with acceptor substrate concentrations >5 [iM. For rat pineal NAT1 expressed in CHO cells, Ebisawa et al. (7) reported a similar decline in NAT activity with increasing 2-AP concentrations. Ferguson et al. (35) reported an apparent tf m of -100 U. M for 2-AF NAT for bacterially expressed NATls from rapid or slow acetylator hamsters. A direct comparison of recombinant hamster NAT1 and NAT2 isozymes in CHO cells by Nagata et al. (32) showed that the rate of O-acetylation of 2-A 7 -hydroxyamino-6-methyldipyrido[ 1,2-a:3',2'-d\imida-zole was ~20-fold greater for NAT1 than NAT2. Conversely, 2-AF NAT activity was -4-fold greater for NAT2 in that study.
Although we and others have shown by Northern analysis (7, 22) , RT-PCR analysis (22) and in situ hybridization (13) that both NATs are expressed in many if not all rat tissues, NAT1* transcripts predominate and native rat NAT2-like activity has not been demonstrated in vivo (14) . Therefore, the demonstration here and by Ebisawa et al. (7) that the recombinant rat NAT2 is enzymatically active raises questions about the role of this rat acetyltransferase in metabolizing aromatic amines. Depending on the relative levels of the two NAT isozymes, the net result of their combined activities in vivo may be to give relatively constant rates of A / -acetylation over a broad substrate range, although NAT activity for some substrates might be modulated in vivo (7) . The data also indicate that at low micromolar arylamine concentrations, NAT1 would play the predominant role in bioactivation of arylamine derivatives in rat liver and other tissues.
In summary, we have shown that bacterially expressed rat and hamster NAT1 and NAT2 have very similar isozymespecific physical and kinetic properties and these are analogous to those reported for their native counterparts in liver cytosol. Both rat and hamster NATls efficiently catalyzed N,O-&cy\-transfer activity implicated in metabolic activation of arylamines, but showed marked substrate inhibition for N-acetylation reactions. Although the NAT2s also have significant N,Oacyltransfer capability, their K m values for arylhydroxamic acids are 1-2 orders of magnitude higher. These recombinant acetyltransferases should be useful for further structure-function studies of arylamine biotransformations in vitro and for determining the biological consequences of their expression in vivo.
